The 3-month on, 2-month off structure preserves that sensitivity and allows natural GH secretion rhythms to reassert themselves during the rest phase
Mechanism of Action The KLOW Blend has been investigated for the complementary mechanisms of its four peptide components
Peptide injections can cut that time down significantly while improving tissue integrity and reducing scar tissue formation
Methylcobalamin, also known as vitamin B12, is traditionally used in the management of vitamin B12 deficiency states, which can manifest in various forms such as pernicious anemia, malabsorption syndromes, and other conditions that cause B12 depletion
Phase 1 oral trial from 20152016 that never reported results
Neurological: convulsions, increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatment, vertigo, headache Endocrine: menstrual irregularities, development of cushingoid state, suppression of fetal intrauterine or childhood growth, lack of secondary response of the adrenal cortex or pituitary gland, particularly in situations of stress such as trauma, surgery or illness, decreased carbohydrate tolerance, manifestations of latent diabetes mellitus, increased requirements of insulin or oral hypoglycemic agents in diabetic patients Ophtalmic: posterior subcapsular cataracts, increased intraocular pressure, glaucoma, exophthalmos Metabolic: negative nitrogen balance due to protein catabolism Psychiatric: euphoria, mood swings, severe depression to frank psychotic manifestations, personality changes, hyperirritability, insomnia Others: anaphylactoid or hypertensive reactions and hypotension or shock-like reaction Cyanocobalamin and hydroxocobalamin: hypervitaminosis and side effects were not observed with their use Dosage and administration Adults Coated tablets: 1 coated tablet 2 times a day
